Oregon Chapter 689
Chapter 689 — Pharmacists; Drug Outlets; Drug SalesDownload Full 2005 Oregon Revised Statutes (coming soon!)
Download Full 2007 Oregon Revised Statutes (coming soon!)
View 2005 version of these codes
Code Resources
Oregon Resources
Oregon Website
Oregon Governor
Oregon Legislature
Oregon Courts
Search this Code
in Google Scholar
on the Web
Google Web Search
MSN Web Search
Yahoo! Web Search
in the News
Google News Search
Google News Archive Search
Yahoo! News Search
in the Blogs
BlawgSearch.com Search
Google Blog Search
Technorati Blog Search
in other Databases
Google Book Search
Chapter 689 —
Pharmacists; Drug Outlets; Drug Sales
2007 EDITION
PHARMACISTS; DRUG OUTLETS; DRUG SALES
OCCUPATIONS AND PROFESSIONS
GENERAL PROVISIONS
689.005 Definitions
689.015 “Practice
of pharmacy” defined
689.025 Policy;
purpose
689.035 Short
title
689.045 Severability
STATE BOARD OF PHARMACY
689.115 Membership;
qualifications; appointment; vacancy
689.125 Term
of office; removal
689.135 General
powers of board; fees
689.139 State
Board of Pharmacy Account; disposition of receipts
689.145 Enforcement
powers of board
689.151 Board
control over licensing, standards and discipline
689.153 Continuing
authority of board upon lapse, suspension, revocation or voluntary surrender of
license or certificate
689.155 Authority
of board over medications, drugs, devices and other materials; rules
689.165 Officers;
executive director
689.175 Compensation
of board members and executive director
689.185 Meetings
689.195 Employees
689.205 Rulemaking
689.207 Authority
of board to require fingerprints
PRACTICE OF PHARMACY
689.225 When
license required; exceptions; possession of drugs; regulation of pharmacy
technicians; rules; penalty
689.255 Qualifications
for licensure by examination
689.265 Qualifications
for licensure by reciprocity
689.275 Renewal
of licenses; rules; fees
689.285 Continuing
pharmacy education; rules; fees
REGULATION OF DRUG OUTLETS
689.305 Registration
of drug outlets; rules
689.315 Application;
rules
689.325 Required
reports
689.335 Certificate
required; reinstatement
DIVERSION PROGRAM
689.342 Pharmacy
Diversion Program Supervisory Council; appointment; term; compensation and
expenses
689.344 Program
director; duties
689.346 Contract
for services to licensees who are chemically dependent; rules
689.348 Referral
in addition to or in lieu of disciplinary action
689.352 Records
and information confidential; participant not subject to other sanctions
689.354 Civil
immunity of board, council, employer and contractors
689.356 Rules;
fees and charges
DISCIPLINE
689.405 Grounds
for discipline; investigation; procedure as contested case
689.445 Penalties
and reinstatement
689.455 Report
of suspected violations; liability for reporting; confidentiality of report
PHARMACY TECHNICIANS
689.486 When
license required; qualifications for licensure; renewal; supervision required
689.490 Board
to establish licensing system; rules; fees
689.495 Provision
of licensing information
689.497 Report
required upon termination of pharmacy technician
689.499 Pharmacy
technician specialized education program; rules
REQUIREMENTS RELATING TO SALES
689.505 Labeling
requirements; rules
689.508 Prescription
records
689.515 Regulation
of generic drugs; substitutions; rules
689.525 Out-of-state
prescriptions
689.555 Agricultural
drugs, nonprescription drugs and certain other substances
MISCELLANEOUS
689.605 Authority
to dispense drugs from hospital pharmacies, drug rooms and penal institutions;
rules
689.615 Display
of certificate or license
689.635 Dispensing
according to naturopathic formulary; effect of filling prescription of
naturopath
689.645 Authority
to administer vaccines and immunizations; Immunization and Vaccination Advisory
Committee; rules
689.655 Authority
to flush intravenous lines and to administer drugs and medical devices; rules;
limitations
PROHIBITED PRACTICES
689.765 Prohibited
practices; complimentary samples; rules
PENALTIES
689.832 Civil
penalties
689.854 Civil
penalty for violation of ORS 689.515
689.995 Criminal
penalties
GENERAL PROVISIONS
689.005
Definitions. As used in this
chapter:
(1) “Administer” means the direct
application of a drug or device whether by injection, inhalation, ingestion, or
any other means, to the body of a patient or research subject by:
(a) A practitioner or the authorized agent
thereof; or
(b) The patient or research subject at the
direction of the practitioner.
(2) “Approved continuing pharmacy
education program” means those seminars, classes, meetings, workshops and other
educational programs on the subject of pharmacy approved by the board.
(3) “Board of pharmacy” or “board” means
the State Board of Pharmacy.
(4) “Continuing pharmacy education” means
professional, pharmaceutical post-graduate education in the general areas of
socio-economic and legal aspects of health care; the properties and actions of
drugs and dosage forms; and the etiology, characteristics and therapeutics of
the disease state.
(5) “Continuing pharmacy education unit”
means the unit of measurement of credits for approved continuing education courses
and programs.
(6) “Deliver” or “delivery” means the
actual, constructive or attempted transfer of a drug or device other than by
administration from one person to another, whether or not for a consideration.
(7) “Device” means an instrument, apparatus,
implement, machine, contrivance, implant, in vitro reagent or other similar or
related article, including any component part or accessory, which is required
under federal or state law to be prescribed by a practitioner and dispensed by
a pharmacist.
(8) “Dispense” or “dispensing” means the
preparation and delivery of a prescription drug pursuant to a lawful order of a
practitioner in a suitable container appropriately labeled for subsequent
administration to or use by a patient or other individual entitled to receive
the prescription drug.
(9) “Distribute” means the delivery of a
drug other than by administering or dispensing.
(10) “Drug” means:
(a) Articles recognized as drugs in the
official United States Pharmacopoeia, official National Formulary, official
Homeopathic Pharmacopoeia, other drug compendium or any supplement to any of
them;
(b) Articles intended for use in the
diagnosis, cure, mitigation, treatment or prevention of disease in a human or
other animal;
(c) Articles (other than food) intended to
affect the structure or any function of the body of humans or other animals;
and
(d) Articles intended for use as a
component of any articles specified in paragraph (a), (b) or (c) of this
subsection.
(11) “Drug order” means a written order, in
a hospital or other inpatient care facility, for an ultimate user of any drug
or device issued and signed by a practitioner, or an order transmitted by other
means of communication from a practitioner, that is immediately reduced to
writing by a pharmacist, licensed nurse or other practitioner.
(12) “Drug outlet” means any pharmacy,
nursing home, shelter home, convalescent home, extended care facility, drug
abuse treatment center, penal institution, hospital, family planning clinic,
student health center, retail store, wholesaler, manufacturer, mail-order
vendor or other establishment with facilities located within or out of this
state that is engaged in dispensing, delivery or distribution of drugs within
this state.
(13) “Drug room” means a secure and lockable
location within an inpatient care facility that does not have a licensed
pharmacy.
(14) “Electronically transmitted” or “electronic
transmission” means a communication sent or received through technological
apparatuses, including computer terminals or other equipment or mechanisms
linked by telephone or microwave relays, or any similar apparatus having
electrical, digital, magnetic, wireless, optical, electromagnetic or similar
capabilities.
(15) “Institutional drug outlet” means
hospitals and inpatient care facilities where medications are dispensed to
another health care professional for administration to patients served by the
hospitals or facilities.
(16) “Intern” means any person who has
completed the junior or third academic year of a course of study at an approved
college of pharmacy and is licensed with the board as an intern.
(17) “Internship” means a professional and
practical experience program approved by the board under the supervision of a
licensed pharmacist registered with the board as a preceptor.
(18) “Itinerant vendor” means all persons
who sell or otherwise distribute nonprescription drugs by passing from house to
house, or by haranguing the people on the public streets or in public places,
or who use the customary devices for attracting crowds and therewith
recommending their wares and offering them for sale.
(19) “Labeling” means the process of
preparing and affixing of a label to any drug container exclusive, however, of
the labeling by a manufacturer, packer or distributor of a nonprescription drug
or commercially packaged legend drug or device. Any such label shall include
all information required by federal and state law or regulation.
(20) “Manufacture” means the production,
preparation, propagation, compounding, conversion or processing of a device or
a drug, either directly or indirectly by extraction from substances of natural
origin or independently by means of chemical synthesis or by a combination of
extraction and chemical synthesis and includes any packaging or repackaging of
the substances or labeling or relabeling of its container, except that this
term does not include the preparation or compounding of a drug by an individual
for their own use or the preparation, compounding, packaging or labeling of a
drug:
(a) By a practitioner as an incident to
administering or dispensing of a drug in the course of professional practice;
or
(b) By a practitioner or by the
practitioner’s authorization under supervision of the practitioner for the
purpose of or as an incident to research, teaching or chemical analysis and not
for sale.
(21) “Manufacturer” means a person engaged
in the manufacture of drugs.
(22) “Nonprescription drug outlet” means
shopkeepers and itinerant vendors registered under ORS 689.305.
(23) “Nonprescription drugs” means drugs
which may be sold without a prescription and which are prepackaged for use by
the consumer and labeled in accordance with the requirements of the statutes
and regulations of this state and the federal government.
(24) “Person” means an individual,
corporation, partnership, association or any other legal entity.
(25) “Pharmacist” means an individual
licensed by this state to engage in the practice of pharmacy.
(26) “Pharmacy” means a place that meets
the requirements of rules of the board, is licensed and approved by the board
where the practice of pharmacy may lawfully occur and includes apothecaries,
drug stores, dispensaries, hospital outpatient pharmacies, pharmacy departments
and prescription laboratories but does not include a place used by a
manufacturer or wholesaler.
(27) “Pharmacy technician” means a person
licensed by the State Board of Pharmacy who assists the pharmacist in the
practice of pharmacy pursuant to rules of the board.
(28) “Practitioner” means a person licensed
and operating within the scope of such license to prescribe, dispense, conduct
research with respect to or administer drugs in the course of professional
practice or research:
(a) In this state; or
(b) In another state or territory of the
(29) “Preceptor” means a pharmacist
licensed and in good standing, registered by the board to supervise the
internship training of a licensed intern.
(30) “Prescription drug” or “legend drug”
means a drug which is:
(a) Required by federal law, prior to
being dispensed or delivered, to be labeled with either of the following
statements:
(A) “Caution: Federal law prohibits
dispensing without prescription”; or
(B) “Caution: Federal law restricts this
drug to use by or on the order of a licensed veterinarian”; or
(b) Required by any applicable federal or
state law or regulation to be dispensed on prescription only or is restricted
to use by practitioners only.
(31) “Prescription” or “prescription drug
order” means a written, oral or electronically transmitted direction, given by
a practitioner authorized to prescribe drugs, for the preparation and use of a
drug. When the context requires, “prescription” also means the drug prepared
under such written, oral or electronically transmitted direction.
(32) “Retail drug outlet” means a place
used for the conduct of the retail sale, administering or dispensing or
compounding of drugs or chemicals or for the administering or dispensing of
prescriptions and licensed by the board as a place wherein the practice of
pharmacy may lawfully occur.
(33) “Shopkeeper” means a business or
other establishment, open to the general public, for the sale or nonprofit
distribution of drugs.
(34) “Unit dose” means a sealed
single-unit container so designed that the contents are administered to the
patient as a single dose, direct from the container. Each unit dose container
must bear a separate label, be labeled with the name and strength of the
medication, the name of the manufacturer or distributor, an identifying lot
number and, if applicable, the expiration date of the medication.
(35) “Wholesale drug outlet” means any
person who imports, stores, distributes or sells for resale any drugs including
legend drugs and nonprescription drugs.
(36) “Class I wholesaler” means any person
operating or maintaining a wholesale distribution center, wholesale business or
any other business in which drugs, medicinal chemicals, or poisons are sold,
dispensed, stocked, exposed or offered for sale at wholesale to a pharmacy or
other legally licensed drug outlets or persons.
(37) “Class II wholesaler” means any
person operating or maintaining a wholesale distribution center, wholesale
business or any other business in which nonprescription drugs are offered for
sale at wholesale to a drug outlet legally authorized to resell. [1979 c.777 §5;
1983 c.402 §1; 1985 c.565 §94; 1987 c.108 §1; 1989 c.608 §1; 1991 c.682 §1;
1993 c.272 §1; 1993 c.571 §1; 1997 c.729 §1; 1999 c.350 §2; 2001 c.623 §6; 2005
c.313 §11]
689.010 [Amended by 1963 c.586 §1; 1967 c.629 §1;
1969 c.514 §1; 1973 c.743 §1; 1975 c.369 §1; 1975 c.686 §8; 1979 c.785 §7;
repealed by 1977 c.842 §2 and 1979 c.777 §59]
689.015
“Practice of pharmacy” defined.
The “practice of pharmacy” means the interpretation and evaluation of
prescription orders; the compounding, dispensing, labeling of drugs and devices
(except labeling by a manufacturer, packer or distributor of nonprescription
drugs and commercially packaged legend drugs and devices); the administering of
vaccines and immunizations pursuant to ORS 689.645; the administering of drugs
and devices to the extent permitted under ORS 689.655; the participation in
drug selection and drug utilization reviews; the proper and safe storage of
drugs and devices and the maintenance of proper records therefor; the
responsibility for advising, where necessary or where regulated, of therapeutic
values, content, hazards and use of drugs and devices; the monitoring of therapeutic
response or adverse effect to drug therapy; and the offering or performing of
those acts, services, operations or transactions necessary in the conduct,
operation, management and control of pharmacy. [1979 c.777 §4; 1999 c.350 §3]
689.025
Policy; purpose. (1) The
practice of pharmacy in the State of Oregon is declared a health care
professional practice affecting the public health, safety and welfare and is
subject to regulation and control in the public interest. It is further
declared to be a matter of public interest and concern that the practice of
pharmacy, as defined in this chapter, merit and receive the confidence of the
public and that only qualified persons be permitted to engage in the practice
of pharmacy in the State of
(2) It is the purpose of this chapter to
promote, preserve and protect the public health, safety and welfare by and
through the effective control and regulation of the practice of pharmacy and of
the registration of drug outlets engaged in the manufacture, production, sale
and distribution of drugs, medications, devices and such other materials as may
be used in the diagnosis and treatment of injury, illness and disease. [1979 c.777
§§2,3; 1985 c.565 §95; 2007 c.438 §1]
689.035
Short title. This chapter
shall be known as the “Oregon Pharmacy Act.” [1979 c.777 §1; 1985 c.565 §96]
689.045
Severability. If any
provision of ORS 167.203, 414.325, 430.405, 435.010, 453.025, 475.005, 475.135,
475.185, 475.840, 475.906 and 616.855 and ORS chapter 689 is declared
unconstitutional or illegal, or the applicability of ORS 167.203, 414.325,
430.405, 435.010, 453.025, 475.005, 475.135, 475.185, 475.840, 475.906 and
616.855 and ORS chapter 689 to any person or circumstances is held invalid by a
court of competent jurisdiction, the constitutionality or legality of the
remaining provisions of ORS 167.203, 414.325, 430.405, 435.010, 453.025,
475.005, 475.135, 475.185, 475.840, 475.906 and 616.855 and ORS chapter 689 and
the application of ORS 167.203, 414.325, 430.405, 435.010, 453.025, 475.005,
475.135, 475.185, 475.840, 475.906 and 616.855 and ORS chapter 689 to other
persons and circumstances shall not be affected and shall remain in full force
and effect without the invalid provision or application. [1979 c.777 §63; 1999
c.605 §6; 1999 c.1051 §137]
Note: 689.045 was enacted into law by the
Legislative Assembly but was not added to or made a part of ORS chapter 689 or
any series therein by legislative action. See Preface to Oregon Revised
Statutes for further explanation.
689.110 [Amended by 1963 c.586 §2; 1965 c.580 §4;
1967 c.159 §1; 1969 c.514 §2; repealed by 1977 c.842 §45 and 1979 c.777 §59]
STATE BOARD
OF PHARMACY
689.115
Membership; qualifications; appointment; vacancy. (1) The State Board of Pharmacy shall
consist of seven members, two of whom shall be representatives of the public,
and the remaining five of whom shall be licensed pharmacists. The members shall
possess the qualifications specified in subsections (2) and (3) of this
section.
(2) The public members of the State Board
of Pharmacy shall be residents of this state who have attained the age of
majority and shall not be nor shall they ever have been a member of the profession
of pharmacy, or persons who have any immediate family in the profession of
pharmacy or persons who have ever had any material financial interest in the
providing of pharmacy service or who have engaged in any activity directly
related to the practice of pharmacy.
(3) The licensed pharmacist members of the
board shall at the time of their appointment:
(a) Be residents of this state;
(b) Be licensed and in good standing to
engage in the practice of pharmacy in this state;
(c) Be engaged in the practice of pharmacy
in this state; and
(d) Have five years of experience in the
practice of pharmacy in this state after licensure.
(4) The Governor shall appoint the members
of the State Board of Pharmacy, subject to the advice and consent of the
Senate, and in accordance with the other provisions of subsection (5) of this
section.
(5) At least five recommendations for
appointment to each vacancy on the board may be made to the Governor by a task
force assembled by the Oregon State Pharmacists Association to represent all of
the interested pharmacy groups. Such nominations shall be recommendations only
and shall not be binding in any manner upon the Governor.
(6) Any vacancy which occurs in the
membership of the board for any reason, including expiration of term, removal,
resignation, death, disability or disqualification, shall be filled by the
Governor in the manner prescribed by subsections (4) and (5) of this section.
The Governor shall fill vacancies which occur by expiration of full terms
within 90 days prior to each date of expiration, and shall fill vacancies which
occur for any other reason within 60 days after each such vacancy occurs. [1979
c.777 §§7,8,9,11; 1987 c.108 §2]
689.120 [Amended by 1967 c.159 §2; repealed by 1969
c.514 §57]
689.125
Term of office; removal. (1)
Except as provided in subsection (2) of this section, members of the State
Board of Pharmacy shall be appointed for a term of four years, except that
members of the board who are appointed to fill vacancies which occur prior to
the expiration of a former member’s full term shall serve the unexpired portion
of such term.
(2)(a) The terms of the members of the
board shall be staggered, so that the terms of no more than two members shall
expire in any year.
(b) The present members of the board shall
serve the balance of their terms.
(c) Any present board member appointed
initially for a term of less than four years shall be eligible to serve for two
additional full terms.
(3) No member of the board shall serve
more than two consecutive full terms. The completion of the unexpired portion
of a full term shall not constitute a full term for purposes of this section.
(4) An appointee to a full term on the
board shall be appointed by the Governor before the expiration of the terms of
the member being succeeded, and shall become a member of the board on the first
day of the state fiscal year next following the appointment. Appointees to
unexpired portions of full terms shall become members of the board on the day
next following such appointment. In the event the number of board members is
increased, the term of any new member shall commence at such time as is
designated in the statute providing for the enlargement of the board.
(5) Each term of office on the board shall
expire at midnight on the last day of the state fiscal year in the final year
of the board member’s term or on the date the successor is appointed and
qualified, except for Senate confirmation, whichever shall later occur.
(6) The Governor may remove a member of
the board, pursuant to the procedures set forth in subsection (7) of this
section upon one or more of the following grounds:
(a) The refusal or inability for any
reason of a board member to perform the duties of a member of the board in an
efficient, responsible and professional manner;
(b) The misuse of office by a member of
the board to obtain personal, pecuniary or material gain or advantage for self
or for another through such office; or
(c) The violation by any member of this
chapter or any of the rules adopted hereunder.
(7) The procedures shall be as stated in
ORS chapter 183 to remove a member of the board from office for any of the
grounds specified by subsection (6) of this section. [1979 c.777 §§10,12; 1985
c.565 §97]
689.130 [Repealed by 1969 c.514 §57]
689.135
General powers of board; fees.
(1) The State Board of Pharmacy shall have such other duties, powers and
authority as may be necessary to the enforcement of this chapter and to the
enforcement of board rules made pursuant thereto, which shall include, but are
not limited to, the following:
(a) Cause to have printed and circulated
annually copies of any changes in the laws relating to pharmacy, controlled
substances, drugs and poisons and the rules adopted to enforce such laws, and
set reasonable charges therefor.
(b) Appoint advisory committees.
(2) The board may join such professional
organizations and associations organized exclusively to promote the improvement
of the standards of the practice of pharmacy for the protection of the health and
welfare of the public and whose activities assist and facilitate the work of
the board.
(3) In addition to any statutory
requirements, the board may require such surety bonds as it deems necessary to
guarantee the performance and discharge of the duties of any officer or
employee receiving and disbursing funds.
(4) The executive director of the board
shall keep the seal of the board and shall affix it only in such manner as may
be prescribed by the board.
(5) The board shall determine within 30
days prior to the beginning of each state fiscal year the fees to be collected
for:
(a) Examinations and reexaminations, which
fee shall not exceed $400.
(b) Pharmacist licenses, which fee shall
not exceed $250.
(c) Pharmacist licensing by reciprocity,
which fee shall not exceed $300.
(d) Intern license, which fee shall not
exceed $50.
(e) Duplicate pharmacist certificate,
which fee shall not exceed $50.
(f) Pharmacist license, delinquent renewal
fee, which fee shall not exceed $50.
(g) Certification of approved providers of
continuing education courses, which fee shall not exceed $300.
(h) Registration of drug outlets other
than pharmacies and renewal of registration, which fee shall not exceed $500.
(i) Initial pharmacy or institutional drug
outlet, which fee shall not exceed $300.
(j) Annual pharmacy or institutional drug
outlet, which fee shall not exceed $300.
(k) Pharmacy or institutional drug outlet
delinquent renewal fee, which fee shall not exceed $200.
(L) Nonprescription drug outlets, which fee
shall not exceed $50.
(m) Nonprescription drug outlet delinquent
renewal fee, which fee shall not exceed $50.
(n) Reinspection fee, which fee shall not
exceed $100.
(o) Drug outlets, other than pharmacies or
institutional drug outlets, delinquent renewal fee, which fee shall not exceed
$100.
(6) All moneys collected either as costs
or fines under ORS 435.010 to 435.130, 453.175, 453.185 and 453.990 and this
chapter shall be paid by the magistrate or other officer receiving them to the
treasurer of the county where the prosecution is conducted. These moneys shall
be applied, first, to the payment of the costs of such prosecution. The
remainder shall be paid by the county treasurer into the State Treasury and, in
the case of:
(a) All moneys except criminal fines,
placed to the credit of the State Board of Pharmacy Account established in ORS
689.139 to be used only for the administration and enforcement of ORS 435.010
to 435.130 and this chapter.
(b) Criminal fines, placed to the credit
of the Criminal Fine and Assessment Account.
(7) Except as provided in subsection (6)
of this section, all moneys received under ORS 435.010 to 435.130, 453.185 and
453.990 and this chapter shall be paid into the State Treasury and placed to
the credit of the State Board of Pharmacy Account to be used only for the
administration and enforcement of ORS 435.010 to 435.130 and this chapter.
(8) The board may receive and expend
funds, in addition to its biennial appropriation, from parties other than the
state, provided:
(a) Such moneys are awarded for the
pursuit of a specific objective which the board is authorized to accomplish by
this chapter, or which the board is qualified to accomplish by reason of its
jurisdiction or professional expertise;
(b) Such moneys are expended for the
pursuit of the objective for which they are awarded;
(c) Activities connected with or
occasioned by the expenditures of such funds do not interfere with or impair
the performance of the board’s duties and responsibilities and do not conflict
with the exercise of the board’s powers as specified by this chapter;
(d) Such moneys are kept in a separate,
special state account; and
(e) Periodic reports are made to the
Governor concerning the board’s receipt and expenditure of such moneys.
(9) The board may assign to each drug
outlet under its jurisdiction, a uniform state number, coordinated where
possible with all other states which adopt the same uniform numbering system.
(10) The board or its authorized
representatives shall also have power to investigate and gather evidence
concerning alleged violations of the provisions of this chapter or of the rules
of the board.
(11) The president and vice president of
the board may administer oaths in connection with the duties of the board.
(12) The books, registers and records of
the board as made and kept by the executive director or under the supervision
of the executive director, subject to the direction of the board, shall be
prima facie evidence of the matter recorded therein, in any court of law.
(13) The board may administer oaths, issue
notices and subpoenas in the name of the board, enforce subpoenas in the manner
authorized by ORS 183.440, hold hearings and perform such other acts as are
reasonably necessary to carry out its duties under this chapter.
(14)(a) Notwithstanding anything in this
chapter to the contrary, whenever a duly authorized representative of the board
finds or has probable cause to believe that any drug or device is adulterated,
misbranded or a new drug, as defined in Section 201(p) of the Federal Food,
Drug and Cosmetic Act, for which there is no approval in effect pursuant to
Section 505(b) of the federal Act nor an approved notice of claimed
investigational exemption pursuant to Section 505(i) of the federal Act, or
otherwise rendered unsafe for use as a result of fire, flood or other natural
disaster, the representative shall affix to such drug or device a tag or other
appropriate marking giving notice that such article is or is suspected of being
adulterated, misbranded, or otherwise rendered unsafe and has been detained or
embargoed and warning all persons not to remove or dispose of such article by
sale or otherwise until provision for removal or disposal is given by the
board, its agent or the court. No person shall remove or dispose of such
embargoed drug or device by sale or otherwise without the permission of the
board or its agent or, after summary proceedings have been instituted, without
permission from the court.
(b) When a drug or device detained or
embargoed under paragraph (a) of this subsection has been declared by such
representative to be adulterated, misbranded or a new drug, or rendered unsafe,
the board shall, as soon as practical thereafter, petition the judge of the
circuit court in whose jurisdiction the article is detained or embargoed for an
order for condemnation of such article. If the judge determines that the drug
or device so detained or embargoed is not adulterated or misbranded or rendered
unsafe, the board shall direct the immediate removal of the tag or other
marking.
(c) If the court finds the detained or
embargoed drug or device is adulterated or misbranded or rendered unsafe, such
drug or device, after entry of the judgment, shall be destroyed at the expense
of the owner under the supervision of a board representative and all court
costs and fees, storage and other proper expense shall be borne by the owner of
such drug or device. When the adulteration or misbranding can be corrected by
proper labeling or processing of the drug or device, the court, after entry of
the judgment and after such costs, fees and expenses have been paid and a good
and sufficient bond has been posted, may direct that such drug or device be
delivered to the owner thereof for such labeling or processing under the supervision
of a board representative. Expense of such supervision shall be paid by the
owner. Such bond shall be returned to the owner of the drug or device on
representation to the court by the board that the drug or device is no longer
in violation of the embargo and the expense of supervision has been paid.
(d) It is the duty of the Attorney General
to whom the board reports any violation of this subsection to cause appropriate
proceedings to be instituted in the proper court without delay and to be prosecuted
in the manner required by law. Nothing in this subsection shall be construed to
require the board to report violations whenever the board believes the public’s
interest will be adequately served in the circumstances by a suitable written
notice or warning.
(15) Except as otherwise provided to the
contrary, the board shall exercise all of its duties, powers and authority in
accordance with ORS chapter 183. [1979 c.777 §20; 1981 c.277 §2; 1983 c.402 §2;
1985 c.565 §98; 1987 c.108 §3; 1991 c.460 §9; 1993 c.571 §3; 2001 c.457 §1;
2003 c.576 §543; 2005 c.726 §11]
689.139
State Board of Pharmacy Account; disposition of receipts. The State Board of Pharmacy Account is
established in the State Treasury, separate and distinct from the General Fund.
All moneys received by the State Board of Pharmacy shall be deposited into the
account and are continuously appropriated to the board to carry out the duties,
functions and powers of the board. Any interest or other income from moneys in
the account shall be credited to the account. [2005 c.726 §10]
689.140 [Amended by 1963 c.586 §3; repealed by 1969
c.514 §57]
689.145
Enforcement powers of board.
The responsibility for enforcement of the provisions of this chapter is vested
in the State Board of Pharmacy. The board shall have all of the duties, powers
and authority specifically granted by and necessary and proper to the
enforcement of this chapter, as well as such other duties, powers and authority
as it may be granted from time to time by law. [1979 c.777 §6; 1985 c.565 §99]
689.150 [Amended by 1969 c.514 §46; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.151
Board control over licensing, standards and discipline. The State Board of Pharmacy shall be
responsible for the control and regulation of the practice of pharmacy in this
state including, but not limited to, the following:
(1) The licensing by examination or by
reciprocity of applicants who are qualified to engage in the practice of
pharmacy under the provisions of this chapter;
(2) The renewal of licenses to engage in
the practice of pharmacy;
(3) The determination and issuance of
standards based on nationally recognized standards of practice and
accreditation criteria for recognition and approval of schools and colleges of
pharmacy whose graduates shall be eligible for licensure in this state, and the
specification and enforcement of requirements for practical training, including
internship;
(4) The enforcement of those provisions of
this chapter relating to the conduct or competence of pharmacists practicing in
this state, and the suspension, revocation or restriction of licenses to engage
in the practice of pharmacy;
(5) The training, qualifications and
employment of pharmacy interns; and
(6) The licensing of pharmacy technicians.
[Formerly 689.245; 2001 c.595 §1; 2005 c.313 §10]
689.153
Continuing authority of board upon lapse, suspension, revocation or voluntary
surrender of license or certificate. The lapse, suspension or revocation of a license or certificate of
registration by the operation of law or by order of the State Board of Pharmacy
or by the decision of a court of law, or the voluntary surrender of a license
by a licensee or of a certificate of registration by the holder of the
certificate, does not deprive the board of jurisdiction to proceed with any
investigation or any action or disciplinary proceeding against the licensee or
certificate holder or revise or render null and void an order of disciplinary
action against the licensee or certificate holder. [2007 c.90 §4]
689.155
Authority of board over medications, drugs, devices and other materials; rules. The State Board of Pharmacy shall also have
the following responsibilities in regard to medications, drugs, devices and
other materials used in this state in the diagnosis, mitigation and treatment
or prevention of injury, illness and disease:
(1) The regulation of the sale at retail,
the administering by pharmacists to the extent provided in ORS 689.645 and
689.655 and the dispensing of medications, drugs, devices and other materials
including the right to seize any such drugs, devices and other materials found
to be detrimental to the public health and welfare by the board after
appropriate hearing as required under ORS chapter 183.
(2) The specifications of minimum professional
and technical equipment, environment, supplies and procedures for the
compounding, administering and dispensing of such medications, drugs, devices
and other materials within the practice of pharmacy and any drug outlet.
(3) The control of the purity and quality
of such medications, drugs, devices and other materials within the practice of
pharmacy and any drug outlet.
(4) The issuance and renewal of
certificates of registration of drug outlets for purposes of ascertaining those
persons engaged in the manufacture and distribution of drugs, receiving and
collecting annual fees therefrom and suspending, revoking or refusing to renew
such registration in the manner provided in this chapter.
(5) In conjunction with the regularly
constituted law enforcement agencies of this state, enforce all laws of the
state which pertain to the practice of pharmacy, the manufacture, production,
sale or distribution of drugs, chemicals and poisons, and to their standard of
strength and purity.
(6) Investigate all complaints of alleged
violations of this chapter and take necessary action as the board may require
or direct.
(7) Pursuant to ORS chapter 183, make such
rules as are necessary and feasible for carrying out ORS 453.175, 453.185,
475.005, 475.135 and 475.185 and this chapter and make rules relating to
controlled substances, designated as such pursuant to ORS 475.025 and 475.035.
(8) At all reasonable hours, in
performance of the duties imposed by this section, enter, or cause its
authorized representatives to enter upon, and examine the premises or records
required by law of any drug outlet under the jurisdiction of the board.
(9) Assist the regularly constituted law
enforcement agencies of this state in enforcing ORS 453.005 to 453.135, 475.005
and 475.135 and this chapter by prosecution in the courts of this state or
otherwise.
(10) Cause to have made a regular
inspection of all pharmacies.
(11) Pursuant to ORS chapter 183, make
such rules as are necessary for pharmacies, drug manufacturers and wholesalers
to sell or otherwise lawfully distribute designated pharmaceutical agents to
licensed optometrists consistent with the provisions of ORS 683.010 to 683.335.
[1979 c.777 §19; 1985 c.565 §100; 1999 c.350 §4; 2001 c.632 §5]
689.160 [Amended by 1969 c.514 §4; 1979 c.785 §8;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.165
Officers; executive director.
(1) The State Board of Pharmacy shall elect from its members a president and
vice president and such other officers as it deems appropriate and necessary to
the conduct of its business. The President of the State Board of Pharmacy shall
preside at all meetings of the board and shall be responsible for the
performance of all of the duties and functions of the board required or
permitted by this chapter. If the president is absent or unable to preside, the
vice president shall preside. Each additional officer elected by the board
shall perform those duties normally associated with their position and such
other duties assigned from time to time by the board.
(2) Officers elected by the board shall
serve terms of one year commencing with the day of their election, and ending
upon election of their successors and shall serve no more than one consecutive
full term in each office to which they are elected.
(3) The board shall employ a licensed
pharmacist who shall be an ex officio member of the board without vote to serve
as a full-time employee of the board in the position of executive director. The
executive director shall be responsible for the performance of the regular
administrative functions of the board and such other duties as the board may
direct. The executive director shall not perform any discretionary or
decision-making functions for which the board is solely responsible. [1979
c.777 §13; 1985 c.565 §101]
689.170 [Amended by 1963 c.586 §4; 1969 c.514 §5;
1973 c.743 §2; 1979 c.514 §1; 1979 c.744 §61; 1979 c.785 §9; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.175
Compensation of board members and executive director. (1) Each member of the State Board of
Pharmacy shall receive compensation for each day on which the member is engaged
in performance of the official duties of the board, and reimbursement for all
expenses incurred in connection with the discharge of such official duties as
provided in ORS 292.495.
(2) The Executive Director of the State
Board of Pharmacy shall receive, as compensation, an annual salary payable
monthly, the amount of which shall be determined by the board, and
reimbursement for all expenses incurred in connection with performance of
official duties, subject to applicable law and to the rules of the Oregon
Department of Administrative Services. [1979 c.777 §14]
689.180 [Amended by 1969 c.514 §3; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.185
Meetings. (1) The State
Board of Pharmacy shall meet at least once every three months to transact its
business. One such meeting held during each fiscal year of the state shall be
designated by rule as the annual meeting and shall be for the purpose of
electing officers and for the reorganization of the board. The board shall meet
at such additional times as it may determine. Such additional meetings may be
called by the president of the board or by majority of members of the board.
(2) The board shall meet at such place as
it may from time to time determine. The place for each meeting shall be
determined prior to giving notice of such meeting and shall not be changed
after such notice is given without adequate subsequent notice.
(3) Notice of all meetings of the board shall
be given in the manner and pursuant to requirements prescribed by the state’s
applicable rules.
(4) A majority of the members of the board
shall constitute a quorum for the conduct of a board meeting and, except where
a greater number is required by ORS 167.203, 414.325, 430.405, 435.010,
453.025, 475.005, 475.135, 475.185, 475.840, 475.906 and 616.855 and this
chapter, or by any rule of the board, all actions of the board shall be by a
majority of a quorum.
(5) All board meetings and hearings shall be
open to the public. The board may, in its discretion and according to law,
conduct any portion of its meeting in executive session closed to the public. [1979
c.777 §15; 1999 c.605 §7; 1999 c.1051 §138]
689.195
Employees. (1) The State
Board of Pharmacy may, in its discretion, employ persons in addition to the
executive director in such other positions or capacities as it deems necessary
to the proper conduct of board business and to the fulfillment of the board’s
responsibilities as defined by this chapter.
(2) The employees of the board other than
the executive director shall receive, as compensation, an annual salary payable
monthly, the amount of which shall be determined by law, and reimbursement for
expenses incurred in connection with performance of their official duties. [1979
c.777 §16; 1985 c.565 §102]
689.205
Rulemaking. The State Board
of Pharmacy shall make, adopt, amend and repeal such rules as may be deemed
necessary by the board, from time to time, for the proper administration and
enforcement of this chapter. Such rules shall be adopted in accordance with the
procedures specified in ORS chapter 183. [1979 c.777 §17; 1985 c.565 §103]
689.207
Authority of board to require fingerprints. For the purpose of requesting a state or nationwide criminal records
check under ORS 181.534, the State Board of Pharmacy may require the
fingerprints of a person who is:
(1) Applying for a license or certificate
that is issued by the board;
(2) Applying for renewal of a license or
certificate that is issued by the board; or
(3) Under investigation by the board. [2005
c.730 §68]
Note: 689.207 was enacted into law by the
Legislative Assembly but was not added to or made a part of ORS chapter 689 or
any series therein by legislative action. See Preface to Oregon Revised
Statutes for further explanation.
689.210 [Amended by 1961 c.216 §1; 1965 c.580 §5;
1967 c.287 §1; 1969 c.514 §6; 1973 c.743 §3a; 1973 c.827 §75; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.215 [1965 c.580 §3; repealed by 1967 c.287 §3]
689.220 [Repealed by 1969 c.514 §57]
PRACTICE OF
PHARMACY
689.225
When license required; exceptions; possession of drugs; regulation of pharmacy
technicians; rules; penalty.
(1) It shall be unlawful for any person to engage in the practice of pharmacy
unless licensed to so practice under the provisions of this chapter. Nothing in
this section prevents physicians, dentists, veterinarians, osteopaths or other
practitioners of the healing arts who are licensed under the laws of this state
from dispensing and administering prescription drugs to their patients in the
practice of their respective professions where specifically authorized to do so
by law of this state.
(2) It shall be unlawful for any person,
not legally licensed as a pharmacist, to take, use or exhibit the title of
pharmacist or the title of druggist or apothecary, or any other title or
description of like import.
(3) In the practice of pharmacy, a
pharmacist is licensed to practice as defined in ORS 689.015, but is not
authorized to possess personally or to store drugs other than in a licensed
pharmacy except for those drugs legally prescribed for the personal use of the
pharmacist. An employee, agent or owner of any registered manufacturer,
wholesaler or pharmacy may lawfully possess legend drugs if the person is
acting in the usual course of the business or employment of the person.
(4) The State Board of Pharmacy shall
adopt rules relating to the use of pharmacy technicians working under the
supervision, direction and control of a licensed pharmacist. For retail and
institutional drug outlets, the board shall adopt rules which include
requirements for training, including provisions for appropriate on-the-job
training, guidelines for adequate supervision, standards and appropriate ratios
for the use of pharmacy technicians. Improper use of pharmacy technicians shall
be subject to the reporting requirements of ORS 689.455.
(5) The mixing of intravenous admixtures
by pharmacy technicians working under the supervision, direction and control of
a licensed pharmacist is authorized and does not constitute the practice of
pharmacy by the pharmacy technicians.
(6) Any person who is found to have
unlawfully engaged in the practice of pharmacy is guilty of a Class A
misdemeanor. [1979 c.777 §21; 1983 c.402 §3; 1985 c.565 §104; 1989 c.608 §2;
1997 c.729 §2; 2001 c.278 §1]
689.230 [Amended by 1967 c.287 §2; 1969 c.514 §7;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.235 [1969 c.514 §8; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.240 [Amended by 1963 c.96 §3; 1967 c.183 §2;
1969 c.514 §9; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.245 [1979 c.777 §18; 1985 c.565 §105; renumbered
689.151 in 1997]
689.250 [Amended by 1955 c.132 §1; 1963 c.96 §4;
1965 c.580 §6; 1967 c.183 §3; 1969 c.514 §10; 1973 c.612 §24; 1975 c.686 §9;
repealed by 1979 c.777 §59]
689.255
Qualifications for licensure by examination. (1) To obtain a license to engage in the practice of pharmacy, an
applicant for licensure by examination shall:
(a) Have submitted a written application
in the form prescribed by the State Board of Pharmacy.
(b) Have attained the age of 18 years.
(c) Be of good moral character and
temperate habits.
(d) Have completed requirements for the
first professional undergraduate degree as certified by a school or college of
pharmacy which has been approved by the board.
(e) Have completed an internship or other
program which has been approved by the board, or demonstrated to the board’s
satisfaction experience in the practice of pharmacy which meets or exceeds the
minimum internship requirements of the board.
(f) Have successfully passed an
examination given by the board.
(g) Have paid the fees specified by the
board for examination and issuance of license.
(2)(a) The examination for licensure
required under subsection (1)(f) of this section shall be given by the board at
least two times during each fiscal year of the state. The board shall determine
the content and subject matter of each examination, the place, time and date of
administration of the examination and those persons who shall have successfully
passed the examination.
(b) The examination shall be prepared to
measure the competence of the applicant to engage in the practice of pharmacy.
The board may employ and cooperate with any organization or consultant in the
preparation and grading of an appropriate examination, but shall retain the
sole discretion and responsibility of determining which applicants have
successfully passed such an examination.
(3)(a) All applicants for licensure by
examination shall obtain professional and practical experience in the practice
of pharmacy concurrent with or after college attendance, or both, under such
terms and conditions as the board shall determine.
(b) The board shall establish standards
for internship or any other program necessary to qualify an applicant for the
licensure examination based on nationally recognized standards of practice and
shall also determine the necessary qualifications of any preceptors used in any
internship or other program.
(4) Any person who has received a first
professional undergraduate degree from a school or college of pharmacy located
outside the United States which has not been approved by the board, but who is
otherwise qualified to apply for a license to practice pharmacy in the State of
Oregon may be deemed to have satisfied the degree requirements of subsection
(1)(d) of this section by verification to the board of the academic record and
graduation of the person and by meeting such other requirements as the board
may establish. The board may require such person to successfully pass an
examination or examinations given or approved by the board to establish
proficiency in English and equivalency of education of such person with
qualified graduates of a degree program referred to in subsection (1)(d) of
this section as a prerequisite of taking the licensure examination provided for
in subsection (1)(f) of this section. [1979 c.777 §22; 1987 c.108 §4; 1999 c.59
§205]
689.260 [Amended by 1969 c.514 §12; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.265
Qualifications for licensure by reciprocity. (1) To obtain a license as a pharmacist by reciprocity, an applicant
for licensure shall:
(a) Have submitted a written application
in the form prescribed by the State Board of Pharmacy.
(b) Have attained the age of 18 years.
(c) Have good moral character and
temperate habits.
(d) Have possessed at the time of initial
licensure as a pharmacist such other qualifications necessary to have been eligible
for licensure at that time in this state.
(e) Have engaged in the practice of
pharmacy for a period of at least one year or have met the internship
requirements of this state within the one-year period immediately previous to
the date of such application.
(f) Have presented to the board proof of
initial licensure by examination and proof that such license and any other
license or licenses granted to the applicant by any other state or states have
not been suspended, revoked, canceled or otherwise restricted for any reason
except nonrenewal or the failure to obtain required continuing education
credits in any state where the applicant is licensed but not engaged in the
practice of pharmacy.
(g) Have successfully passed an
examination in jurisprudence given by the board.
(h) Have paid the fees specified by the
board for issuance of a license.
(i) Have submitted to the board proof of a
professional undergraduate degree that meets the requirements of ORS 689.255
(4), if the applicant has received a first professional undergraduate degree
from a school or college of pharmacy located outside the
(2) No applicant shall be eligible for
licensure by reciprocity unless the state in which the applicant was initially
licensed as a pharmacist also grants reciprocal licensure to pharmacists duly
licensed by examination in this state, under like circumstances and conditions.
[1979 c.777 §23; 2001 c.585 §1]
689.270 [Amended by 1963 c.586 §5; 1969 c.514 §14;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.275
Renewal of licenses; rules; fees. (1) Each pharmacist shall apply for renewal of license annually no
later than June 30 or no later than such date as may be specified by rule of
the State Board of Pharmacy. The board shall renew the license of each
pharmacist who is qualified to engage in the practice of pharmacy.
(2) The board shall specify by rule the
procedures to be followed, in addition to those specified by ORS 689.285, and
the fees to be paid for renewal of licenses.
(3)(a) All pharmacists in good standing
who have been licensed pharmacists for at least 20 years and who are retired
from practice of pharmacy are exempt from further payment of license fees until
they again engage in the practice of pharmacy. No retired pharmacist shall
engage in the practice of pharmacy without first paying all fees for the year
in which the pharmacist resumes practice and producing evidence satisfactory to
the board of continued professional competence.
(b) Failure to comply with the
requirements of paragraph (a) of this subsection shall be considered the
practice of pharmacy without a license. [1979 c.777 §24; 2007 c.768 §51]
689.280 [1965 c.580 §2; 1967 c.183 §4; 1969 c.514 §13;
1973 c.743 §4; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.285
Continuing pharmacy education; rules; fees. (1) The Legislative Assembly finds and declares that:
(a) The continuous introduction of new
medical agents and the changing concepts of the delivery of health care
services in the practice of pharmacy make it essential that a pharmacist
undertake a continuing education program in order to maintain professional
competency and improve professional skills;
(b) The state has a basic obligation to
regulate and control the profession of pharmacy in order to protect the public
health and welfare of its citizens; and
(c) It is the purpose of this chapter to
protect the health and welfare of
(2) All pharmacists licensed in the State
of
(3) In accordance with applicable
provisions of ORS chapter 183, the board shall make reasonable rules:
(a) Prescribing the procedure and criteria
for approval of continuing pharmacy education programs, including the number of
hours of courses of study necessary to constitute a continuing pharmacy
education unit and the number of continuing pharmacy education units required
annually for renewal of a pharmacist license.
(b) Prescribing the scope of the
examinations given by the board including grading procedures.
(c) Prescribing the content of the form to
be submitted to the board certifying completion of an approved continuing
pharmacy education program.
(d) Necessary to carry out the provisions
of this chapter.
(e) Prescribing the completion of:
(A) A pain management education program
approved by the board and developed in conjunction with the Pain Management
Commission established under ORS 409.500; or
(B) An equivalent pain management
education program, as determined by the board.
(4) In adopting rules pursuant to
subsection (3) of this section, the board shall consider:
(a) The need for formal regularly
scheduled pharmacy education programs.
(b) Alternate methods of study including
home-study courses, seminars or other such programs for those persons who, upon
written application to the board and for good cause shown, demonstrate their
inability to attend regularly scheduled formal classroom programs.
(c) The necessity for examinations or
other evaluation methods used to ensure satisfactory completion of the
continuing pharmacy education program.
(5) The board may contract for the
providing of educational programs to fulfill the requirements of this chapter.
The board is further authorized to treat funds set aside for the purpose of
continuing education as state funds for the purpose of accepting any funds made
available under federal law on a matching basis for the promulgation and
maintenance of programs of continuing education. In no instance shall the board
require a greater number of hours of study than it provides or approves in the
State of
(6) The board may levy an additional fee
of up to $10 for each license renewal to carry out the provisions of this
chapter. [1979 c.777 §26; 1983 c.402 §5; 1985 c.565 §106; 1993 c.571 §6; 1993
c.742 §55; 2001 c.281 §1; 2005 c.162 §3]
689.290 [1969 c.514 §56; 1971 c.92 §2; 1973 c.743 §5;
1977 c.745 §43; repealed by 1977 c.842 §45 and 1979 c.777 §59]
REGULATION OF
DRUG OUTLETS
689.305
Registration of drug outlets; rules. (1) All drug outlets shall annually register with the State Board of
Pharmacy.
(2)(a) Each drug outlet shall apply for a
certificate of registration in one or more of the following classifications:
(A) Retail drug outlet.
(B) Institutional drug outlet.
(C) Manufacturing drug outlet.
(D) Wholesale drug outlet.
(E) Nonprescription drug outlet.
(b) No individual who is employed by a
corporation which is registered under any classification listed in paragraph
(a) of this subsection need register under the provisions of this section.
(3) The board shall establish by rule
under the powers granted to it under ORS 689.155 and 689.205 the criteria which
each drug outlet must meet to qualify for registration in each classification
designated in subsection (2)(a) of this section. The board may issue various
types of certificates of registration with varying restrictions to the
designated outlets where the board deems it necessary by reason of the type of
drug outlet requesting a certificate.
(4) It shall be lawful for a drug outlet
registered under this section to sell and distribute nonprescription drugs.
Drug outlets engaging in the sale and distribution of such items shall not be
deemed to be improperly engaged in the practice of pharmacy. [1979 c.777 §30;
1993 c.571 §8]
689.310 [Amended by 1953 c.126 §2; 1963 c.96 §5;
1967 c.183 §5; 1969 c.514 §15; 1979 c.336 §2; repealed by 1977 c.842 §45 and
1979 c.777 §59]
689.315
Application; rules. (1) The
State Board of Pharmacy shall specify by rule the registration procedures to be
followed, including but not limited to specification of forms for use in
applying for such certificates of registration and times, places and fees for
filing such application.
(2) Applications for certificates of
registration shall include the following information about the proposed drug
outlet:
(a) Ownership;
(b) Location;
(c) Identity of pharmacist licensed to
practice in the state, who shall be the pharmacist in charge of the drug
outlet, where one is required by this chapter, and such further information as
the board may deem necessary; and
(d) The identity of any person who has
incident of ownership in a pharmacy who also has a financial interest in any
long term care facility, as defined in ORS 442.015.
(3) Manufacturers and wholesalers shall
keep all records and files of their transactions for a period of three years
from the date of the inception of such records and files.
(4)(a) Manufacturers and wholesalers shall
acquire a separate registration for each place at which they carry on their
business as a manufacturer or wholesaler within this state.
(b) Certificates of registration issued by
the board pursuant to this chapter shall not be transferable or assignable and
shall be conspicuously displayed at each registered place of business.
(5) The board shall specify by rule
minimum standards for the professional responsibility in the conduct of any
drug outlet that has employees or personnel engaged in the practice of
pharmacy. The board is specifically authorized to require that the portion of
the facility to which such certificate of registration applies be operated only
under the direct supervision of no less than one pharmacist licensed to
practice in this state and not otherwise, and to provide such other special
requirements as deemed necessary. [1979 c.777 §31a; 1985 c.565 §107; 1993 c.571
§9]
689.320 [Amended by 1963 c.586 §6; 1965 c.157 §1;
1967 c.261 §1; 1969 c.514 §16; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.325
Required reports. (1) All
registered drug outlets shall report to the State Board of Pharmacy the
occurrence of any of the following changes within the times specified by the
board by rule:
(a) Permanent closing;
(b) Change of ownership, management,
location or pharmacist in charge; or
(c) Any and all other matters and
occurrences as the board may require by rule.
(2) Disasters, accidents and emergencies
which may affect the strength, purity or labeling of drugs, medications,
devices or other materials used in the diagnosis or the treatment of injury,
illness and disease shall be immediately reported to the board. [1979 c.777 §32;
1993 c.571 §10]
689.330 [Amended by 1955 c.94 §1; 1957 c.598 §1;
1963 c.96 §6; 1969 c.514 §18; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.335
Certificate required; reinstatement. (1) No drug outlet designated in ORS 689.305 shall be operated until a
certificate of registration has been issued to said facility by the State Board
of Pharmacy. Upon the finding of a violation of ORS 689.305 or 689.405, the
board may impose one or more of the penalties under ORS 689.445.
(2) Reinstatement of a certificate that
has been suspended, revoked or restricted by the board may be granted in
accordance with the procedures specified by ORS 689.445 (2). [1979 c.777 §33;
1981 c.277 §3]
689.340 [Amended by 1969 c.514 §19; 1973 c.612 §25;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
DIVERSION
PROGRAM
689.342
Pharmacy Diversion Program Supervisory Council; appointment; term; compensation
and expenses. (1) There is
established a Pharmacy Diversion Program Supervisory Council consisting of five
members appointed by the State Board of Pharmacy for the purpose of developing
and implementing a diversion program for licensees regulated under this chapter
who are chemically dependent. No current board member or staff shall serve on
the council.
(2) The term of office of each member is
two years, but a member serves at the pleasure of the board. Before the
expiration of the term of a member, the board shall appoint a successor whose
term begins July 1 next following. A member is eligible for reappointment. If
there is a vacancy for any cause, the board shall make an appointment to become
immediately effective for the unexpired term.
(3) A member of the council is entitled to
compensation and expenses as provided in ORS 292.495.
(4) The council shall select one of its
members as chairperson and another as vice chairperson, for such terms and with
duties and powers the council determines necessary for the performance of the
functions of such office.
(5) A majority of the members of the
council constitutes a quorum for the transaction of business. [1989 c.667 §1;
2005 c.313 §1; 2007 c.70 §313]
689.344
Program director; duties.
(1) Subject to approval of the State Board of Pharmacy, the Pharmacy Diversion
Program Supervisory Council may appoint a program director to serve at the
pleasure of the council. The program director shall be an employee of the
board.
(2) The program director shall administer,
under the control and supervision of the council, the diversion program for
licensees who are chemically dependent.
(3) The board may appoint such employees
as may be necessary to carry out the duties of the council under the control
and supervision of the council. [1989 c.667 §2; 2005 c.313 §2; 2007 c.70 §314]
689.346
Contract for services to licensees who are chemically dependent; rules. The State Board of Pharmacy may enter into
contracts to provide services for licensees who are chemically dependent and
may, in accordance with ORS chapter 183, adopt rules necessary for the
administration of a diversion program for licensees who are chemically
dependent. [1989 c.667 §3; 2007 c.70 §315]
689.348
Referral in addition to or in lieu of disciplinary action. (1) In addition to or in lieu of any
disciplinary action under ORS 689.405, the State Board of Pharmacy may refer a
licensee who is chemically dependent to a diversion program administered by the
Pharmacy Diversion Program Supervisory Council.
(2) The council shall report to the board
and provide all pertinent information concerning any licensee who is referred
to the council under subsection (1) of this section and fails to complete the
diversion program or fails to participate in the diversion program in good
faith. [1989 c.667 §4; 2005 c.313 §3]
689.350 [Amended by 1965 c.356 §1; 1967 c.183 §6;
1969 c.514 §20; repealed by 1977 c.842 §2 and 1979 c.777 §59]
689.352
Records and information confidential; participant not subject to other
sanctions. (1) All records
of the Pharmacy Diversion Program Supervisory Council are confidential and
shall not be subject to public disclosure, nor shall the records be admissible
as evidence in any judicial proceeding.
(2) The members, employees, contractors
and past or present clients of the council shall not be subject to the
disclosure requirements in ORS 689.455, nor shall they disclose information or
be examined regarding any participant in the program, except as provided in ORS
689.348 (2).
(3) Any licensee who in good faith
voluntarily participates in an approved diversion program and successfully
completes the program shall not be subject to sanction unless the licensee is
suspected of a violation of this chapter other than ORS 689.405 (1)(d). [1989
c.667 §5; 2005 c.313 §4]
689.354
Civil immunity of board, council, employer and contractors. The State Board of Pharmacy, the Pharmacy
Diversion Program Supervisory Council and their members, employees and
contractors shall be immune from any civil liability arising from simple
negligent acts taken pursuant to ORS 689.342 to 689.356. [1989 c.667 §6; 2005
c.313 §5]
689.356
Rules; fees and charges. In
addition to any other powers granted by ORS 689.342 to 689.356, the State Board
of Pharmacy may adopt necessary and proper rules for administration of ORS
689.342 to 689.356 including, but not limited to, establishing fees and charges
to carry out its legal responsibilities, subject to prior approval by the
Oregon Department of Administrative Services and a report to the Emergency
Board prior to adopting the fees and charges. The fees and charges established
under this section shall not exceed the cost of administering the program of
the Pharmacy Diversion Program Supervisory Council, as authorized by the
Legislative Assembly within the board’s budget, or as the budget may be
modified by the Emergency Board, and shall be maintained in an account separate
from other funds of the board. [1989 c.667 §7; 1991 c.703 §32; 2005 c.313 §6]
689.360 [1965 c.580 §8; 1969 c.514 §17; repealed by
1977 c.842 §45 and 1979 c.777 §59]
DISCIPLINE
689.405
Grounds for discipline; investigation; procedure as contested case. (1) The State Board of Pharmacy may refuse
to issue or renew, or may suspend, revoke or restrict the license of any person
or the certificate of registration of any drug outlet upon one or more of the
following grounds:
(a) Unprofessional conduct as that term is
defined by the rules of the board.
(b) Repeated or gross negligence.
(c) Incapacity of a nature that prevents a
person from engaging in the activity for which the person is licensed with
reasonable skill, competence and safety to the public.
(d) Habitual or excessive use of
intoxicants, drugs or controlled substances.
(e) Being found guilty by the board of a
violation of subparagraph (B) of this paragraph, or by a court of competent
jurisdiction of one or more of the following:
(A) A felony, as defined by the laws of
this state; or
(B) Violations of the pharmacy or drug
laws of this state or rules pertaining thereto, or of statutes, rules or regulations
of any other state, or of the federal government.
(f) Fraud or intentional misrepresentation
by a licensee or registrant in securing or attempting to secure the issuance or
renewal of a license.
(g) Engaging or aiding and abetting an
individual to engage in the practice of pharmacy without a license, or falsely
using the title of pharmacist.
(h) Aiding and abetting an individual in
performing the duties of a pharmacy technician without licensing.
(i) Being found by the board to be in
violation of any of the provisions of ORS 435.010 to 435.130, 453.025, 453.045,
475.035 to 475.190, 475.805, 475.840 to 475.980 or this chapter or rules
adopted pursuant to ORS 435.010 to 435.130, 453.025, 453.045, 475.035 to
475.190, 475.805, 475.840 to 475.980 and this chapter.
(j) Disciplinary action by another state
regarding a license, based upon acts by the licensee similar to acts described
in this subsection. A certified copy of the record of disciplinary action of
the state taking the disciplinary action is conclusive evidence thereof.
(2) Upon receipt of a complaint under this
chapter, the board shall conduct an investigation as described under ORS
676.165.
(3) Actions taken under subsection (1) of
this section shall be considered a contested case under ORS chapter 183. [1979
c.777 §§27,28; 1981 c.277 §4; 1985 c.131 §4; 1987 c.736 §1; 1995 c.440 §11;
1997 c.729 §3; 1997 c.791 §48; 2005 c.313 §12]
689.410 [Amended by 1963 c.586 §7; 1965 c.580 §7;
1969 c.514 §25; 1977 c.745 §44; repealed by 1979 c.777 §59]
689.413 [1969 c.514 §26; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.415 [1969 c.514 §27; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.420 [Repealed by 1969 c.514 §57]
689.423 [1971 c.734 §143; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.425 [1969 c.514 §30; repealed by 1971 c.734 §21]
689.430 [Amended by 1969 c.514 §29; repealed by 1971
c.734 §21]
689.435 [1971 c.734 §144; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.440 [Repealed by 1969 c.514 §57]
689.445
Penalties and reinstatement.
(1) Upon the finding of the existence of grounds for discipline of any person
holding a license, seeking a license or renewal of a license under the
provisions of ORS 435.010 to 435.030, 475.125 and 475.135 and this chapter, the
State Board of Pharmacy may impose one or more of the following penalties:
(a) Suspension of the offender’s license
for a term to be determined by the board;
(b) Revocation of the offender’s license;
(c) Restriction of the offender’s license
to prohibit the offender from performing certain acts or from engaging in the
practice of pharmacy in a particular manner for a term to be determined by the
board;
(d) A civil penalty not to exceed:
(A) $1,000 for each offense committed by
an individual; and
(B) $10,000 for each offense committed by
a drug outlet;
(e) Refusal to renew offender’s license;
or
(f) Placement of the offender on probation
and supervision by the board for a period to be determined by the board.
(2) Any person whose license issued
pursuant to this chapter has been suspended, revoked or restricted pursuant to
this chapter, whether voluntarily or by action of the board, shall have the
right, at reasonable intervals, to petition the board for reinstatement of such
license. Such petition shall be made in writing and in the form prescribed by
the board. Upon investigation and hearing, the board may in its discretion
grant or deny such petition, or it may modify its original finding to reflect
any circumstances which have changed sufficiently to warrant such
modifications. Pardon and restoration of civil rights to any person formerly
licensed by the board does not obligate the board to restore revoked,
restricted or suspended licenses.
(3) Nothing in this chapter shall be
construed as barring criminal prosecutions for violations of ORS 435.010 to
435.130, 453.025, 453.045, 475.035 to 475.190, 475.805, 475.840 to 475.980 and
this chapter where such violations are deemed as criminal offenses in other
statutes of this state or of the
(4) Civil penalties under this section
shall be imposed as provided in ORS 183.745.
(5) All penalties recovered under ORS
435.010 to 435.130, 453.025, 453.045, 475.035 to 475.190, 475.805, 475.840 to
475.980 and this chapter shall be deposited into the State Board of Pharmacy
Account established in ORS 689.139. [1979 c.777 §29; 1985 c.131 §5; 1991 c.734 §75;
1995 c.440 §12; 1997 c.729 §4; 2005 c.726 §12; 2007 c.90 §1]
689.450 [Amended by 1969 c.514 §47; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.455
Report of suspected violations; liability for reporting; confidentiality of
report. (1) A pharmacist or
pharmacy technician shall report to the State Board of Pharmacy any suspected
violations of this chapter or of ORS 475.005 to 475.285 and 475.840 to 475.980.
(2) Any pharmacist or pharmacy technician
who reports to the board as required by subsection (1) of this section in good
faith shall not be subject to an action for civil damages as a result thereof.
(3) Any information that the board obtains
pursuant to ORS 689.405 or 689.445 or this section is confidential as provided
under ORS 676.175. [1985 c.131 §3; 1995 c.440 §40; 1997 c.791 §49; 2001 c.595 §4]
689.460 [1973 c.743 §11; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.475 [1967 c.636 §2; 1969 c.514 §32; repealed by
1977 c.842 §45 and 1979 c.777 §59]
689.480 [1967 c.636 §3; 1969 c.514 §33; repealed by
1977 c.842 §45 and 1979 c.777 §59]
689.485 [1967 c.636 §4; 1969 c.514 §34; repealed by
1977 c.842 §45 and 1979 c.777 §59]
PHARMACY
TECHNICIANS
689.486
When license required; qualifications for licensure; renewal; supervision
required. (1) It shall be
unlawful for any person to perform the duties of a pharmacy technician or use
the title of pharmacy technician unless licensed to do so under the provisions
of this chapter.
(2) To be licensed to perform the duties
of a pharmacy technician, a person shall:
(a) Submit a license application in the
manner prescribed by the State Board of Pharmacy; and
(b) Pay the license fee established by the
board.
(3) The license application prescribed by
the board shall include, but not be limited to:
(a) The name and address of the applicant;
(b) The educational qualifications of the
applicant;
(c) The work history of the applicant; and
(d) The applicant’s criminal offender
record of any conviction or of any arrest less than one year old on which there
has been no acquittal or dismissal.
(4) A license under this section expires
annually. To renew a license to perform the duties of a pharmacy technician, a
person shall:
(a) Submit the application for renewal of
a license in the form prescribed by the board;
(b) Pay the license renewal fee
established by the board;
(c) Pay the fee for delinquent license
renewal, if applicable;
(d) Provide updated information regarding
educational qualifications, work history and criminal arrest and conviction
history; and
(e) Comply with all other requirements for
license renewal established by the board.
(5) No person may employ an individual to
perform the duties of a pharmacy technician unless the individual is licensed
to perform the duties of a pharmacy technician under this chapter.
(6) A person licensed to perform the
duties of a pharmacy technician may perform the duties of a pharmacy technician
only under the supervision, direction and control of a licensed pharmacist. [1997
c.729 §6; 2001 c.595 §2; 2005 c.313 §7]
Note: Section 14, chapter 313, Oregon Laws 2005,
provides:
Sec.
14. A person registered as a
pharmacy technician under ORS 689.486 on the effective date of this 2005 Act
[June 28, 2005] shall be considered to be licensed as a pharmacy technician in
accordance with the amendments to ORS 689.486 and 689.490 by sections 7 and 8
of this 2005 Act. [2005 c.313 §14]
689.490
Board to establish licensing system; rules; fees. (1) In accordance with any applicable
provisions of ORS chapter 183, the State Board of Pharmacy, by rule, shall
establish a licensing system for persons who perform the duties of a pharmacy
technician. The licensing system shall include but not be limited to the
following provisions:
(a) Prescribing the form and content of
and the procedures for submitting an application for the issuance or renewal of
a technician license.
(b) Prescribing the fee for the original
license and for renewal of a license in an amount not to exceed $50 and the fee
for delinquent license renewal in an amount not to exceed $50.
(2) The board may refuse to issue or
renew, or may suspend, revoke or restrict a technician license:
(a) For any reason listed under ORS
689.405 (1);
(b) If the applicant is not authorized to
work for hire under
(c) For any other grounds that the board,
in its discretion, believes would disqualify the applicant for a license.
(3) Denial of a license under subsection
(2) of this section shall be considered a contested case under ORS chapter 183.
[1997 c.729 §7; 2001 c.595 §3; 2005 c.313 §8]
689.495
Provision of licensing information. (1) Upon the written request of a pharmacist, the State Board of
Pharmacy shall provide the name, address, educational qualifications, work
history, technician license history and criminal arrest and conviction history
of any pharmacy technician licensed with the board. Information provided by the
board pursuant to a request under this section shall be in writing and may be
provided to the requester by means of facsimile or other electronic
transmission or the United States Postal Service.
(2) For purposes of this section:
(a) “Written request” includes but is not
limited to a request received by means of facsimile or other electronic
transmission.
(b) “Work history” includes but is not
limited to information reported to the board pursuant to ORS 689.497 to the
extent the information is not exempt from disclosure under ORS 676.175. [1997
c.729 §8; 2001 c.595 §5; 2005 c.313 §9]
689.497
Report required upon termination of pharmacy technician. (1) A pharmacy that terminates a pharmacy
technician shall report the termination to the State Board of Pharmacy. In the
sole discretion of the pharmacy, the pharmacy may report the reason for the
termination.
(2) A pharmacy reporting the termination
of a pharmacy technician under subsection (1) of this section shall provide the
pharmacy technician an opportunity to issue a statement accompanying the report
of termination. The statement of the pharmacy technician may include any
mitigating factors or other information the pharmacy technician deems relevant
to the termination.
(3) A pharmacy, pharmacist, pharmacy
technician or any other person who, in good faith, submits a report of
termination of a pharmacy technician under the provisions of this section is
not liable for any civil damages as a result of submitting the report.
(4) The information provided to the board
pursuant to this section is:
(a) Subject to disclosure as provided in
ORS 689.495; and
(b) Admissible as evidence for any purpose
in any civil proceeding before a court, agency, board or third-party dispute
resolution tribunal.
(5) Nothing in subsection (3) of this
section shall affect the admissibility in evidence of the records of a pharmacy
or pharmacist that pertain to the work history or termination of employment of
a pharmacy technician. [2001 c.595 §7]
689.499
Pharmacy technician specialized education program; rules. (1)(a) The State Board of Pharmacy may by
rule identify activities performed by a pharmacy technician for which a
specialized education program may be required.
(b) If the board identifies an activity
requiring specialized education under this subsection, the board shall approve
no fewer than two specialized education programs to provide the specialized
education.
(c) Upon receipt of evidence satisfactory
to the board that a pharmacy technician has satisfactorily completed a
specialized education program approved by the board, the board shall note the
specialized education on the license of the pharmacy technician.
(2) The board may establish standards for
renewal or revocation of a notation of specialized education under this
section.
(3) As used in this section, “specialized
education program” means:
(a) A program providing education for
persons desiring licensure as pharmacy technicians that is approved by the
board and offered by an accredited college or university that grants a two-year
degree upon successful completion of the program; or
(b) A structured program approved by the
board and designed to educate pharmacy technicians in one or more specific
issues of patient health and safety that is offered by:
(A) An organization recognized by the board
as representing pharmacists or pharmacy technicians;
(B) An employer recognized by the board as
representing pharmacists or pharmacy technicians; or
(C) A trade association recognized by the
board as representing pharmacies. [2005 c.313 §16]
REQUIREMENTS
RELATING TO SALES
689.505
Labeling requirements; rules.
(1)(a) Except as specifically provided by law, no person shall distribute or
dispense any drug without affixing to the authorized container a clear and
legible label, either printed or written, bearing the name of the drug and the
name and place of business of the person distributing or dispensing the drug,
and any other information required by state law or rules or federal law or
regulations under whose supervision the drug is delivered or dispensed.
(b) Labeling requirements regarding any
drug may be changed or exemption therefrom granted by the State Board of
Pharmacy in the form of a special permit if the board determines that a change
or exemption is in the best interest of public health and safety.
(2)(a) No manufacturer or wholesaler
subject to ORS 689.305 shall sell or otherwise distribute, or offer to sell or
otherwise distribute, any drug for use in a:
(A) Parcel, package or container not
bearing a label specifying the name, active ingredients or contents, quality
and quantity of the drug.
(B) Misbranded parcel, package or
container.
(b) A parcel, package or container is
misbranded:
(A) If its labeling is false or misleading
in any particular.
(B) Unless it bears a label containing the
name and business address of the manufacturer, packer, distributor or
wholesaler, and an accurate statement of the quantity of the drug in terms of
weight, measure or numerical count, exclusive of wrappers, cartons, containers
or other materials packed with such drug.
(C) In case it contains controlled
substances which the board finds and by rule designates after reasonable notice
and opportunity for hearing to be habit forming, unless it bears the statement “Warning--May
Be Habit Forming.”
(D) Unless it bears a label with adequate
directions for the safe use of the drug for specified conditions, and adequate
warning against use in those pathological conditions or by children where such
use may be dangerous to the health or welfare of a user.
(E) Unless it bears a label with true
representations of the intended uses of the drug and no false claims or
representations are made of the drug in accompanying literature or advertising.
(3) This section does not apply to
parcels, packages or containers containing:
(a) Drugs prepared and packaged solely for
use by a pharmacist in compounding prescriptions or for dispensing in dosage
unit form upon a prescription, except that such parcels, packages or containers
must bear the name and business address of the manufacturer and, if different,
the name and business address of the distributor of the drug, and the legend “Caution:
Federal Law Prohibits Dispensing Without Prescription” or an equivalent legend.
(b) Drugs intended solely for use in the
professional diagnosis of disease, except that such parcels, packages or
containers shall bear the statement “Diagnostic Reagent--For Professional Use
Only.”
(c) Coloring agents, emulsifiers,
excipients, flavorings, lubricants, preservatives and other like inactive ingredients
used in the manufacture of drugs.
(4) The board shall by rule exempt from
any labeling or packaging requirement of this section drugs which are, in
accordance with the practice of the trade, to be processed, labeled or repacked
in substantial quantities at establishments other than those where originally
processed or packed. However, such drugs must not be adulterated or misbranded
upon removal from such processing, labeling or repacking establishment.
(5) A pharmacist or pharmacy intern shall
not dispense, on the prescription of a practitioner, any drug without affixing
to the container thereof a clear and legible label. The label may be printed or
written. Except as provided in subsection (6) of this section, the pharmacist
or pharmacy intern shall state or cause to be stated on the label the
following:
(a) The name of the drug. If the dispensed
drug does not have a brand name, the prescription label shall indicate the
generic name of the drug dispensed along with the name of the drug distributor or
manufacturer, its quantity per unit and the directions for its use stated in
the prescription. However, if the drug is a compound, the quantity per unit
need not be stated;
(b) The name of the practitioner
prescribing the drug;
(c) The name and place of business of the
pharmacist or the name and place of business of the pharmacy for which the
pharmacist or pharmacy intern is acting;
(d) The name of the patient; and
(e) When applicable and as determined by
the State Board of Pharmacy, an expiration date after which the patient should
not use the drug.
(6) If the prescribing practitioner so
directs, the prescription label shall not state the name and quantity per unit
of the drug.
(7) The State Board of Pharmacy shall
determine those drugs which must bear an expiration date under subsection
(5)(e) of this section.
(8) As used in this section, “compound”
means a drug containing two or more medically active ingredients.
(9) No person shall deliver or dispense
any drug for use by the ultimate consumer without labeling the drug container
as required in this section.
(10) In addition to the labeling
requirements imposed by subsections (1) to (9) of this section, the board may
impose by rule requirements for drug code imprints on solid dose legend drugs. [1979
c.777 §34a; 1993 c.571 §13]
689.508
Prescription records. The
original record of every prescription filled by a pharmacy must be kept on file
at the pharmacy. The prescription record must contain the date of the
transaction and the brand name, or if the drug has no brand name, the generic
name and the name of the manufacturer of any drug substituted pursuant to ORS
689.515. If the prescription may be communicated to the pharmacy by oral or
electronic means, the prescription information may be recorded and stored in an
electronic form that allows for ready retrieval. Prescriptions maintained in
the file required under this section must be readily accessible to the State
Board of Pharmacy for inspection. [2003 c.103 §2]
689.510 [Amended by 1953 c.433 §1; 1971 c.650 §39;
1973 c.792 §44; 1977 c.688 §1; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.515
Regulation of generic drugs; substitutions; rules. (1) As used in this section unless the
context requires otherwise:
(a) “Brand name” means the proprietary or
trade name selected by the manufacturer and placed upon a drug, its container,
label or wrapping at the time of packaging.
(b) “Dosage form” means the physical
formulation or medium in which the product is intended, manufactured and made
available for use, including but not limited to tablets, capsules, oral
solutions, aerosols, ointments, inhalers and suppositories, and the particular
form of which utilizes a specific technology or mechanism to control, enhance
or direct the release, targeting, systemic absorption or other delivery of a
dosage regimen in the body.
(c) “Generic name” means the official
title of a drug or drug ingredients published in the latest edition of the
official Pharmacopoeia, Homeopathic Pharmacopoeia or Formulary.
(d) “Substitute” means to dispense without
the prescriber’s express authorization a different drug product in place of the
drug ordered or prescribed.
(e) “Therapeutically equivalent” means
drugs that are approved by the United States Food and Drug Administration for
interstate distribution and the Food and Drug Administration has determined
that the drugs will provide essentially the same efficacy and toxicity when
administered to an individual in the same dosage regimen.
(2) Except as limited by subsections (3)
and (5) of this section, unless the purchaser instructs otherwise, the
pharmacist may substitute as follows:
(a) A drug product with the same generic
name in the same strength, quantity, dose and dosage form as the prescribed
drug which is, in the pharmacist’s professional opinion, therapeutically
equivalent.
(b) When the prescriber is not reasonably
available for consultation and the prescribed drug does not utilize a unique
delivery system technology, an oral tablet, capsule or liquid form of the prescribed
drug so long as the form dispensed or administered has the same strength, dose
and dose schedule and is therapeutically equivalent to the drug prescribed.
(3) A practitioner may specify in writing,
by a telephonic communication or by electronic transmission that there shall be
no substitution for the specified brand name drug in any prescription. The
phrase “no substitution” or the notation “N.S.” must be in the practitioner’s
handwriting or, if the prohibition was communicated by telephonic communication
or electronic transmission, in the pharmacist’s handwriting and shall not be
preprinted or stamped or initialed on the prescription form.
(4) Every pharmacy shall post a sign in a
location easily seen by patrons at the counter where prescriptions are
dispensed or administered stating that, “This pharmacy may be able to
substitute a less expensive drug which is therapeutically equivalent to the one
prescribed by your doctor unless you do not approve.” The printing on the sign
shall be in block letters not less than one inch in height. If the pharmacist
has reasonable cause to believe that the purchaser cannot read the sign or
comprehend its content, the pharmacist shall endeavor to explain the meaning of
the sign.
(5) A pharmacist shall substitute a drug
product under this section only when there will be a savings in or no increase
in cost to the purchaser.
(6) If the practitioner prescribes a drug
by its generic name, the pharmacist shall, consistent with reasonable
professional judgment, dispense or administer the lowest retail cost, effective
brand which is in stock.
(7) Except as provided in subsection (8)
of this section, when a pharmacist dispenses a substituted drug as authorized
by subsection (2) of this section, the pharmacist must label the prescription
container with the name of the dispensed drug. If the dispensed drug does not
have a brand name, the prescription label shall indicate the generic name of
the drug dispensed along with the name of the drug manufacturer.
(8) A prescription dispensed by a
pharmacist shall bear upon the label the name of the medication in the
container or shall be labeled as intended by the prescriber.
(9) The substitution of any drug by a
licensed pharmacist or the pharmacist’s employer pursuant to this section does
not constitute the practice of medicine.
(10) No substitution of drugs made by a
pharmacist or the pharmacist’s employer in accordance with this section and any
rules that the State Board of Pharmacy may adopt thereunder shall constitute
evidence of negligence if the substitution was made within reasonable and
prudent practice of pharmacy or if the substituted drug was accepted in a
generally recognized formulary or government list.
(11) Failure of a practitioner to specify
that no substitution is authorized does not constitute evidence of negligence
unless the practitioner knows that the health condition of the patient for whom
the practitioner is prescribing warrants the use of the brand name drug product
and not the substituted drug. [1979 c.777 §35; 1983 c.402 §4; 1985 c.565 §110;
1987 c.108 §5; 1989 c.706 §22; 1991 c.734 §76; part renumbered 689.854 and
689.857 in 1991; 1993 c.534 §1; 1993 c.571 §14; 1999 c.350 §5; 2001 c.589 §1;
2001 c.623 §7a]
689.520 [Amended by 1965 c.466 §2; 1967 c.291 §2;
1969 c.314 §89; 1969 c.514 §35; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.525
Out-of-state prescriptions.
(1) A prescription written by a practitioner licensed in a state or territory
of the
(a) That it was issued pursuant to a valid
patient-practitioner relationship; and
(b) That it is authentic.
(2) However, if the practitioner writing
the prescription is not known to the pharmacist, the pharmacist shall obtain
proof to a reasonable certainty of the validity of the prescription.
(3) The provisions of ORS 689.515
authorizing generic substitution shall not apply to prescriptions described in
this section unless authorized on the prescription. [1979 c.777 §36; 1981 c.666
§10; 1987 c.108 §6; 1993 c.571 §15; 1997 c.153 §1]
689.530 [Amended by 1969 c.514 §36; 1977 c.688 §2;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.535 [1979 c.777 §37; 1981 c.217 §1; 1985 c.565 §111;
repealed by 2003 c.102 §2]
689.540 [Amended by 1969 c.514 §37; 1977 c.688 §3;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.545 [1979 c.249 §1; 1981 c.388 §2; repealed by
2003 c.102 §2]
689.550 [Amended by 1965 c.466 §1; 1967 c.291 §3;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.555
Agricultural drugs, nonprescription drugs and certain other substances. (1) Nothing in this chapter prohibits the
sale by any person of agricultural or garden spray, sheep dip, blue stone,
copperas, squirrel poison, fly paper, ant poison, gopher poison, insect powder,
poultry vermifuge and arsenic sprays when they are in original unbroken
packages, prepared and labeled with official poison labels and showing antidotes.
(2) Nothing in this chapter requires or
authorizes the licensing or regulation of the sale of economic poisons, which
includes any substance or mixture of substances intended to be used for
preventing, destroying, repelling or mitigating any and all insects, fungi,
weeds, parasites, or other plant or animal pest, collectively or individually,
which may infest or be detrimental to vegetation or any domestic animal or fowl
life. [1979 c.777 §40; 1985 c.565 §112]
689.560 [Amended by 1969 c.514 §42; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.565 [1999 c.874 §§1,2,3,4; repealed by 2007
c.272 §13]
Note: 689.565 is repealed July 1, 2008. See
sections 13 and 15, chapter 272, Oregon Laws 2007. 689.565 (2005 Edition) is
set forth for the user’s convenience.
689.565
Discounts from pharmacies for prescription drug purchases; requirements;
limitations; actions for violations; remedies. (1) A person shall not sell, market,
promote, advertise or otherwise distribute any card or other purchasing mechanism
or device that is not insurance that purports to offer discounts or access to
discounts from pharmacies for prescription drug purchases when:
(a) Such card or other purchasing
mechanism or device does not expressly state in bold and prominent type, prominently
placed, that the discounts are not insurance;
(b) Such discounts are not specifically
authorized by an individual and separate contract with each pharmacy listed in
conjunction with the card or other purchasing mechanism or device; or
(c) The discounts or access to discounts
offered, or the range of discounts or access to the range of discounts offered,
are misleading, deceptive or fraudulent.
(2) Any person who sells, markets,
promotes, advertises or otherwise distributes any card or other purchasing
mechanism or device that is not insurance that purports to offer discounts or
access to discounts from pharmacies for prescription drug purchases in this
state shall designate a resident of this state as an agent for service of
process and register the agent with the Secretary of State.
(3) The Attorney General or a person,
firm, trade association, private corporation or municipal or other public
corporation may maintain an action to enjoin any act in violation of
subsections (1) to (7) of this section and for the recovery of damages.
(4) An action for violation of subsections
(1) to (7) of this section may be brought:
(a) In the county where the plaintiff
resides;
(b) In the county where the plaintiff
conducts business; or
(c) In the county where the card or other
purchasing mechanism or device was sold, marketed, promoted, advertised or
otherwise distributed.
(5)(a) If the court finds that the
defendant has violated any of the provisions of subsections (1) to (7) of this
section, the court shall enjoin the defendant from continuing the acts that are
in violation of subsections (1) to (7) of this section.
(b) It is not necessary, except to recover
for actual damages under paragraph (c)(B) of this subsection, that actual
damages to the plaintiff be alleged or proved in order to maintain an action
under subsections (3) to (7) of this section.
(c) In addition to injunctive relief, the
plaintiff in the action shall be entitled to recover from the defendant:
(A) $100 per card or other purchasing mechanism
or device sold, marketed, promoted, advertised or otherwise distributed within
this state, or $10,000, whichever is greater;
(B) Three times the amount of the actual
damages, if any, sustained;
(C) Reasonable attorney fees;
(D) Costs; and
(E) Any other relief that the court deems
proper.
(6) An action under subsections (3) to (7)
of this section shall be commenced within two years after the date on which the
violation of subsections (1) to (7) of this section occurred or within two
years after the person bringing the action discovered, or in the exercise of
reasonable diligence should have discovered, the occurrence of the violation of
subsections (1) to (7) of this section. The period of limitation provided in
this subsection may be extended for a period of 180 days if the person bringing
the action proves by a preponderance of the evidence that the failure to timely
commence the action was caused by conduct of the defendant that was solely
calculated to induce the plaintiff to refrain from or postpone commencement of
the action.
(7) The remedies prescribed in subsections
(3) to (7) of this section are cumulative and in addition to any other
applicable criminal, civil or administrative penalties.
(8) Nothing in subsections (1) to (7) of
this section shall be construed to apply to:
(a) Eye or vision care services, glasses
or contact lenses provided by an optometrist or ophthalmologist;
(b) A benefit administered by a health
insurer, or health care service contractor or health maintenance organization
as defined by ORS 750.005;
(c) A benefit administered by, or under
contract with, the State of
(d) A customer discount or membership card
issued by a store or buying club for use at that store or buying club.
Note: 689.565 was enacted into law by the
Legislative Assembly but was not added to or made a part of ORS chapter 689 or
any series therein by legislative action. See Preface to Oregon Revised
Statutes for further explanation.
689.570 [Amended by 1969 c.514 §40; 1973 c.829 §69;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.580 [Amended by 1969 c.514 §45; repealed by 1973
c.743 §9 and by 1973 c.829 §71]
689.590 [Amended by 1965 c.580 §9; 1969 c.514 §44;
1973 c.427 §35; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.595 [1969 c.514 §43; repealed by 1973 c.427 §36
(689.596 enacted in lieu of 689.595)]
689.596 [1973 c.427 §37 (enacted in lieu of
689.595); repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.600 [Amended by 1969 c.514 §39; repealed by 1977
c.842 §45 and 1979 c.777 §59]
MISCELLANEOUS
689.605
Authority to dispense drugs from hospital pharmacies, drug rooms and penal
institutions; rules. (1) In
a hospital or long term care facility having a pharmacy and employing a
pharmacist, the pharmacy and pharmacist are subject to the requirements of this
chapter, except that in a hospital when a pharmacist is not in attendance,
pursuant to standing orders of the pharmacist, a registered nurse supervisor on
the written order of a person authorized to prescribe a drug may withdraw such
drug in such volume or amount as needed for administration to or treatment of
an inpatient or outpatient until regular pharmacy services are available in
accordance with the rules adopted by the board. However, the State Board of Pharmacy
may grant an exception to the requirement for a written order by issuing a
special permit authorizing the registered nurse supervisor in a hospital to
dispense medication on the oral order of a person authorized to prescribe a
drug. An inpatient care facility which does not have a pharmacy must have a
drug room. In an inpatient care facility having a drug room as may be
authorized by rule of the Department of Human Services, the drug room is not
subject to the requirements of this chapter relating to pharmacies. However, a
drug room must be supervised by a pharmacist and is subject to the rules of the
State Board of Pharmacy. When a pharmacist is not in attendance, any person
authorized by the prescriber or by the pharmacist on written order may withdraw
such drug in such volume or amount as needed for administration to or treatment
of a patient, entering such withdrawal in the record of the responsible
pharmacist.
(2) In a hospital having a drug room, any
drug may be withdrawn from storage in the drug room by a registered nurse
supervisor on the written order of a licensed practitioner in such volume or
amount as needed for administration to and treatment of an inpatient or
outpatient in the manner set forth in subsection (1) of this section and within
the authorized scope of practice.
(3) A hospital having a drug room shall
cause accurate and complete records to be kept of the receipt, withdrawal from
stock and use or other disposal of all legend drugs stored in the drug room.
Such record shall be open to inspection by agents of the board and other
qualified authorities.
(4) In an inpatient care facility other
than a hospital, the drug room shall contain only prescribed drugs already
prepared for patients therein and such emergency drug supply as may be
authorized by rule by the Department of Human Services.
(5) The requirements of this section shall
not apply to facilities described in ORS 441.065.
(6) A registered nurse who is an employee
of a local health department established under the authority of a county or
district board of health and registered by the board under ORS 689.305 may,
pursuant to the order of a person authorized to prescribe a drug or device,
dispense a drug or device to a client of the health department for purposes of
caries prevention, birth control or prevention or treatment of a communicable
disease. Such dispensing shall be subject to rules jointly adopted by the board
and the Department of Human Services.
(7) The board shall adopt rules
authorizing a pharmacist to delegate to a registered nurse the authority to
withdraw prescription drugs from a manufacturer’s labeled container for
administration to persons confined in penal institutions including, but not
limited to, adult and juvenile correctional facilities. A penal institution, in
consultation with a pharmacist, shall develop policies and procedures regarding
medication management, procurement and distribution. A pharmacist shall monitor
a penal institution for compliance with the policies and procedures and shall
perform drug utilization reviews. The penal institution shall submit to the
board for approval a written agreement between the pharmacist and the penal
institution regarding medication policies and procedures. [1979 c.777 §38; 1979
c.785 §9d; 1985 c.565 §113; 1989 c.526 §1; 1993 c.272 §2; 1993 c.571 §16; 1995
c.523 §3; 2003 c.617 §2]
689.610 [Amended by 1969 c.514 §41; repealed by 1977
c.842 §45 and 1979 c.777 §59]
689.615
Display of certificate or license. (1) The holder of any certificate or license granted under this
chapter shall display it conspicuously in the pharmacy or place of business to
which it applies.
(2) All pharmacist certificates issued by
the State Board of Pharmacy shall bear the signatures of all members and
officers of the board.
(3) On payment by the applicant of the fee
prescribed in ORS 689.135, the board may issue a new certificate to a
pharmacist if the applicant has lost the certificate or the certificate has
been destroyed. [1979 c.777 §25; 1985 c.565 §114; 1987 c.108 §7; 1993 c.571 §17]
689.620 [Amended by 1965 c.545 §4; 1969 c.514 §38;
1973 c.697 §10; 1975 c.686 §10; 1977 c.745 §45; repealed by 1977 c.842 §45 and
1979 c.777 §59]
689.625 [1975 c.686 §12; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.630 [Repealed by 1965 c.46 §1]
689.635
Dispensing according to naturopathic formulary; effect of filling prescription
of naturopath. The
dispensing of plant and animal substances prescribed by a naturopathic
physician licensed under ORS chapter 685 in accordance with the formulary
established by this section and ORS 685.010, 685.030, 685.145 and dispensed by
a licensed pharmacist or the employee thereof may be filled by a pharmacist
according to the terms of the prescription. The filling of such a prescription
shall not constitute evidence of negligence on the part of the pharmacist or
the employee if the prescription is dispensed within the reasonable and prudent
practices of pharmacy. [1989 c.945 §4; 1993 c.571 §18]
689.640 [Repealed by 1969 c.514 §57]
689.645
Authority to administer vaccines and immunizations; Immunization and
Vaccination Advisory Committee; rules. (1) In accordance with rules adopted by the State Board of Pharmacy
under ORS 689.205, a pharmacist may administer:
(a) Vaccines and immunizations to persons
who are at least 18 years of age; and
(b) Influenza vaccines to persons who are
at least 15 years of age.
(2) The board is authorized to issue, to
licensed pharmacists who have completed training accredited by the Centers for
Disease Control and Prevention, the American Council on Pharmaceutical
Education or a similar health authority or professional body, certificates of
special competency in the administration of vaccines and immunizations to
persons more than 15 years of age.
(3) The board shall adopt rules relating
to the reporting of the administration of vaccines and immunizations to a
patient’s primary health care provider and to the Department of Human Services.
(4) The board shall adopt rules requiring
pharmacists to establish protocols for the administration of vaccines and
immunizations to persons who are at least 18 years of age and for the
administration of influenza vaccines to persons who are at least 15 years of
age.
(5) The board shall convene a volunteer
Immunization and Vaccination Advisory Committee consisting of no more than nine
members for the purpose of advising the board in promulgating rules under this
section. The committee shall consist of one representative from the Department
of Human Services, two representatives from the Oregon Medical Board, two
representatives from the Oregon State Board of Nursing and two representatives
from the State Board of Pharmacy and no more than two pharmacists other than
the representatives from the State Board of Pharmacy. [1999 c.350 §3b; 2005 c.312
§1]
689.650 [1965 c.545 §6; 1969 c.314 §90; 1969 c.514 §31;
repealed by 1973 c.697 §21]
689.655
Authority to flush intravenous lines and to administer drugs and medical devices;
rules; limitations. (1) Only
as provided in this section and in accordance with rules adopted by the State
Board of Pharmacy under ORS 689.205, a pharmacist may:
(a) In collaboration with and under an
order from a physician, nurse practitioner or physician assistant practicing
within the scope of practice allowed by law, flush heparin or saline through
existing intravenous lines that are connected to a person;
(b) In collaboration with and under an
order from a physician, nurse practitioner or physician assistant practicing
within the scope of practice allowed by law, attach an infusion pump or enteric
feeding pump to existing intravenous lines or enteric feeding lines that are
connected to a person, and activate the pump;
(c) Administer drugs and devices in a
medical emergency within a health care facility in the presence of and under
the direction of a physician or nurse practitioner; and
(d) Administer a drug or device to a
person in the course of teaching the person to self-administer the drug or
device that the person will be required routinely to self-administer as part of
a course of therapy ordered by a physician, nurse practitioner or physician
assistant practicing within the scope of practice allowed by law.
(2) Nothing in this section shall be
construed to allow a pharmacist to establish an intravenous or enteric line or
to attach or activate a pump for any intrathecal medication. [1999 c.350 §3e]
689.660 [1965 c.545 §7; 1971 c.650 §40; 1971 c.734 §141;
1973 c.697 §8; repealed by 1977 c.745 §54 and 1977 c.842 §45]
689.665 [1975 c.369 §§3,5; 1979 c.785 §10; repealed
by 1977 c.842 §45 and 1979 c.777 §59]
689.670 [1975 c.686 §2; repealed by 1977 c.842 §43
and 1979 c.777 §59]
689.675 [1975 c.686 §3; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.680 [1975 c.686 §4; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.685 [1975 c.686 §5; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.690 [1975 c.686 §6; repealed by 1979 c.777 §59]
689.695 [1975 c.686 §7; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.705 [1955 c.326 §1; 1967 c.260 §1; repealed by
1969 c.514 §57]
689.710 [1955 c.326 §2; repealed by 1969 c.514 §57]
689.715 [1955 c.326 §3; 1967 c.345 §1; repealed by
1969 c.514 §57]
689.720 [1955 c.326 §4; 1957 c.350 §1; 1963 c.96 §7;
1967 c.183 §7; 1969 c.514 §21; repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.725 [1955 c.326 §5; 1969 c.514 §28; 1973 c.743 §7;
repealed by 1977 c.842 §45 and 1979 c.777 §59]
689.730 [1955 c.326 §6; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.735 [1955 c.326 §7; 1969 c.514 §22; renumbered
689.810]
689.740 [1955 c.326 §8; 1969 c.514 §23; renumbered
689.815]
689.745 [1955 c.326 §9; repealed by 1977 c.842 §45
and 1979 c.777 §59]
689.750 [1955 c.326 §10; 1969 c.514 §24; repealed by
1977 c.842 §45 and 1979 c.777 §59]
689.755 [1955 c.326 §11; repealed by 1969 c.514 §57]
689.760 [1955 c.326 §12; repealed by 1969 c.514 §57]
PROHIBITED
PRACTICES
689.765
Prohibited practices; complimentary samples; rules. (1) No drugs shall be dispensed to the
public by means of automatic vending machines.
(2) As used in this section, “automatic
vending machine” means any mechanical device or contrivance whereby the
purchaser is able to secure drugs.
(3) No person shall adulterate for the
purpose of sale any drug in such manner as to render it injurious to health, or
knowingly sell or offer for sale any adulterated drug.
(4) No person shall manufacture, compound
or sell or offer for sale or cause to be manufactured, compounded, sold or
offered for sale any drug, compound or preparation for internal or external use
under or by a name recognized in the United States Pharmacopoeia, Homeopathic
Pharmacopoeia or National Formulary which differs from the standard of strength
and purity specified therein as official at the time of manufacture,
compounding, sale or offering for sale.
(5) No person shall manufacture, compound,
sell or offer for sale, or cause to be manufactured, sold or offered for sale,
any drug, the strength and purity of which falls below the professed standard
of strength and purity under which it is sold.
(6) No person shall sell, give away,
barter, dispense, distribute, buy, receive or possess any prescription drug
except as authorized by law.
(7) No manufacturer or wholesaler shall
sell or otherwise distribute, or offer to sell or otherwise distribute, any
drug or device except to a person legally authorized to resell, dispense or
otherwise redistribute such drug or device. The board may grant an exemption
from the requirement of this subsection in the form of a special permit if the
board finds that an exemption is in the best interest of the public health and
safety.
(8) Any practitioner who receives any
complimentary samples of any controlled substance, as defined in ORS 475.005,
shall keep the samples in a securely locked, substantially constructed cabinet
and shall maintain a record of receipts and withdrawals from each inventory of
samples. The record requirements shall be specified by rule of the licensing
board that has jurisdiction over the practitioner’s license. The licensing
board may inspect the records and the inventory of samples.
(9)(a) No person may sell, purchase or
trade or offer to sell, purchase or trade any drug sample.
(b) As used in paragraph (a) of this
subsection, “drug sample” means a unit of a drug, subject to this chapter, that
is not intended to be sold and is intended to promote the sale of the drug, and
includes a coupon or other form which may be redeemed for a drug.
(10) For purposes of this section and ORS
678.375, distribution of prepackaged complimentary samples of medications by a
nurse practitioner or clinical nurse specialist with prescription writing
authority shall not constitute dispensing when the sample medication is within
the established formulary for that nurse practitioner or clinical nurse specialist.
[1979 c.777 §39; 1985 c.131 §6; 1987 c.108 §8; 1987 c.736 §2; 1993 c.571 §19;
2003 c.103 §3; 2005 c.462 §9]
Note: Section 3f, chapter 350, Oregon Laws 1999,
provides:
Sec.
3f. Nothing in this 1999 Act
shall be construed to allow a pharmacist to prescribe drugs or to dispense or
administer any drug or device that requires a prescription without a
prescription or order of a practitioner authorized to prescribe drugs. [1999
c.350 §3f]
689.805 [1969 c.514 §49; repealed by 1979 c.777 §59]
689.810 [Formerly 689.735; 1979 c.744 §62; repealed
by 1979 c.777 §59]
689.815 [Formerly 689.740; 1975 c.484 §1; repealed
by 1979 c.777 §59]
689.825 [1973 c.533 §2; 1975 c.369 §2; 1979 c.785 §11;
repealed by 1979 c.777 §59]
689.830 [1975 c.218 §2; repealed by 1979 c.777 §59]
PENALTIES
689.832
Civil penalties. (1) In
addition to any other liability or penalty provided by law, the State Board of
Pharmacy may impose a civil penalty for any violation of the provisions of this
chapter or ORS chapter 475 or any rule of the board. A civil penalty imposed
under this subsection may not exceed $1,000 for each violation by an individual
and $10,000 for each violation by a drug outlet.
(2) All penalties recovered under this
section shall be deposited into the State Board of Pharmacy Account established
in ORS 689.139.
(3) Any civil penalty under this section
shall be imposed in the manner provided in ORS 183.745.
(4) Notwithstanding ORS 183.745, the
person to whom the notice is addressed shall have 10 days from the date of
service of the notice in which to make written application for a hearing before
the board. [1981 c.217 §3; 1991 c.734 §77; 1993 c.571 §20; 1995 c.79 §348; 2005
c.726 §13; 2007 c.90 §2]
689.835 [1975 c.218 §3; 1979 c.785 §12; repealed by
1979 c.777 §59]
689.837 [1981 c.217 §4; repealed by 1993 c.571 §30]
689.840 [1975 c.218 §4; repealed by 1979 c.777 §59]
689.842 [1981 c.217 §5; repealed by 1993 c.571 §30]
689.845 [1975 c.218 §6; 1979 c.785 §13; repealed by
1979 c.777 §59]
689.847 [1981 c.217 §6; 1989 c.706 §23; repealed by
1991 c.734 §122]
689.850 [1975 c.218 §5; repealed by 1979 c.777 §59]
689.852 [1981 c.217 §7; 1991 c.734 §78; repealed by
1993 c.571 §30]
689.854
Civil penalty for violation of ORS 689.515. (1) In addition to all other penalties provided by law every person
who violates ORS 689.515 or any rule adopted thereunder may incur a civil
penalty of up to $250 for every such violation.
(2) The penalty imposed under this section
may be remitted or mitigated upon such terms and conditions as the State Board
of Pharmacy considers proper and consistent with the public health and safety.
(3) Civil penalties under this section
shall be imposed as provided in ORS 183.745.
(4) Civil penalties recovered under this
section shall be deposited into the State Board of Pharmacy Account established
in ORS 689.139. [Formerly part of 689.515; 2005 c.726 §14]
689.855 [Formerly 453.310; repealed by 1979 c.777 §59]
689.857 [1981 c.217 §8; 1991 c.734 §79; subsection
(2) formerly part of 689.515; repealed by 1993 c.571 §30]
689.860 [Formerly 453.320; repealed by 1979 c.777 §59]
689.865 [Formerly 453.020; 1973 c.743 §8; 1975 c.218
§7; 1979 c.785 §14; repealed by 1979 c.777 §59]
689.880 [1977 c.611 §3; repealed by 1979 c.777 §59]
689.885 [1977 c.611 §2; repealed by 1979 c.777 §59]
689.890 [1977 c.611 §4; repealed by 1979 c.777 §59]
689.895 [1977 c.255 §2; 1979 c.249 §2; repealed by
1979 c.777 §59]
689.990 [Subsection (12) of 1965 Replacement Part
enacted as 1955 c.326 §13; 1967 c.158 §1; 1969 c.514 §54; repealed by 1979
c.777 §59]
689.992 [Repealed by 1967 c.158 §2]
689.995
Criminal penalties. (1)
Violation of any provision of this chapter or of any rule of the State Board of
Pharmacy is a misdemeanor.
(2) Failure to comply with any notice,
citation or subpoena issued by the board under ORS 689.135 (13) is a
misdemeanor. Each day during which the violation continues is a separate
offense.
(3) Refusal to furnish information
required under this chapter or willfully furnishing false information, is a
misdemeanor.
(4) Any attempt to secure or the securing
of registration or licensure for any person under any certificate, license or
permit authorized by this chapter by making or causing to be made any false
representations is a misdemeanor. [1979 c.777 §41; 1985 c.131 §7; 1985 c.565 §115;
1993 c.571 §22]
_______________